These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30853959)

  • 1. Cognate Interaction With CD4
    Eisel D; Das K; Dickes E; König R; Osen W; Eichmüller SB
    Front Immunol; 2019; 10():219. PubMed ID: 30853959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Th1 polarization in the tumor microenvironment upregulates the myeloid-derived suppressor-like function of macrophages.
    Nonaka K; Saio M; Umemura N; Kikuchi A; Takahashi T; Osada S; Yoshida K
    Cell Immunol; 2021 Nov; 369():104437. PubMed ID: 34530344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 5. CD206
    Heng Y; Zhu X; Lin H; Jingyu M; Ding X; Tao L; Lu L
    J Transl Med; 2023 Mar; 21(1):167. PubMed ID: 36864443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
    Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
    PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer T cell activation increases iNOS
    Paul S; Chhatar S; Mishra A; Lal G
    J Immunother Cancer; 2019 Aug; 7(1):208. PubMed ID: 31387637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhang W; Xu L; Zhang X; Xu J; Jin JO
    Front Immunol; 2023; 14():1213467. PubMed ID: 37720226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
    Fujimura T; Aiba S
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32707850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-derived suppressor cells attenuate TH1 development through IL-6 production to promote tumor progression.
    Tsukamoto H; Nishikata R; Senju S; Nishimura Y
    Cancer Immunol Res; 2013 Jul; 1(1):64-76. PubMed ID: 24777249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 Immune Mechanisms Driven by the Response to Infection with Attenuated Rabies Virus Result in Changes in the Immune Bias of the Tumor Microenvironment and Necrosis of Mouse GL261 Brain Tumors.
    Bongiorno EK; Garcia SA; Sauma S; Hooper DC
    J Immunol; 2017 Jun; 198(11):4513-4523. PubMed ID: 28461570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
    Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
    J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
    Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
    ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CSF1R-targeted chimeric antigen receptor-modified NK92MI & T cells on tumor-associated macrophages.
    Zhang P; Zhao S; Wu C; Li J; Li Z; Wen C; Hu S; An G; Meng H; Zhang X; Yang L
    Immunotherapy; 2018 Aug; 10(11):935-949. PubMed ID: 30149762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redefining Tumor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment.
    Wu K; Lin K; Li X; Yuan X; Xu P; Ni P; Xu D
    Front Immunol; 2020; 11():1731. PubMed ID: 32849616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repolarization of Tumor-Infiltrating Myeloid Cells for Augmentation of CAR T Cell Therapies.
    Luo W; Napoleon JV; Zhang F; Lee YG; Wang B; Putt KS; Low PS
    Front Immunol; 2022; 13():816761. PubMed ID: 35250995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor-associated macrophage in breast cancer biology.
    Choi J; Gyamfi J; Jang H; Koo JS
    Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron chelated melanin-like nanoparticles for tumor-associated macrophage repolarization and cancer therapy.
    Rong L; Zhang Y; Li WS; Su Z; Fadhil JI; Zhang C
    Biomaterials; 2019 Dec; 225():119515. PubMed ID: 31590119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.